{"transactions":[{"id":876594,"issuer":{"id":8441,"kind":"organization","name":"Genprex, Inc."},"owners":[{"id":64221,"kind":"person","name":"Berger Mark Stanley","position":1,"cik":"0001700283","reported_name":"Berger Mark Stanley","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-02-27T23:34:18.000Z","date":"2026-02-27","kind":"tax_withholding","planned":false,"acquired":false,"shares":7168,"price":2,"value":14336.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld on February 27, 2026 to satisfy tax withholding obligations in connection with the vesting of Restricted Stock Units (\"RSUs\") previously granted under the Genprex, Inc. 2018 Equity Incentive Plan (as amended and restated effective June 30, 2025)."}],"balance_after":21692,"source":{"system":"sec-edgar","filing":"0001437749-26-006154","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595248/000143774926006154/rdgdoc.xml","form_type":"4"}},{"id":959357,"issuer":{"id":8441,"kind":"organization","name":"Genprex, Inc."},"owners":[{"id":64221,"kind":"person","name":"Berger Mark Stanley","position":1,"cik":"0001700283","reported_name":"Berger Mark Stanley","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-12-23T22:35:14.000Z","date":"2025-12-22","kind":"grant","planned":false,"acquired":true,"shares":28500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This award of Restricted Stock Units (\"RSUs\") is granted under the Genprex, Inc. (the \"Company\") 2018 Equity Incentive Plan (as amended and restated effective June 30, 2025, the \"EIP\") and vests in installments of 50% on February 27, 2026 and the remaining 50% on February 27, 2027, provided that the recipient continues to serve as a Service Provider (as defined in the Company's EIP) through the applicable vesting dates. Vested RSUs will be paid in shares of the Company's common stock, $0.001 par value, on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This total represents the number of shares of Common Stock beneficially owned following this reported transaction and the 1-for-50 reverse stock split of the Company's Common Stock effected as of October 21, 2025."}],"balance_after":28860,"source":{"system":"sec-edgar","filing":"0001437749-25-038735","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595248/000143774925038735/rdgdoc.xml","form_type":"4"}},{"id":1097574,"issuer":{"id":8441,"kind":"organization","name":"Genprex, Inc."},"owners":[{"id":64221,"kind":"person","name":"Berger Mark Stanley","position":1,"cik":"0001700283","reported_name":"Berger Mark Stanley","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-07-01T21:52:13.000Z","date":"2025-06-30","kind":"tax_withholding","planned":false,"acquired":false,"shares":4500,"price":0.2279,"value":1025.55,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld on June 30, 2025 to satisfy tax withholding obligations in connection with the vesting of Restricted Stock Units (\"RSUs\") previously granted under the Genprex, Inc. (the \"Company\") 2018 Equity Incentive Plan."}],"balance_after":17971,"source":{"system":"sec-edgar","filing":"0001437749-25-021819","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595248/000143774925021819/rdgdoc.xml","form_type":"4"}},{"id":1258676,"issuer":{"id":8441,"kind":"organization","name":"Genprex, Inc."},"owners":[{"id":64221,"kind":"person","name":"Berger Mark Stanley","position":1,"cik":"0001700283","reported_name":"Berger Mark Stanley","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-02-20T01:01:36.000Z","date":"2025-02-18","kind":"tax_withholding","planned":false,"acquired":false,"shares":585,"price":0.41,"value":239.85,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld on February 18, 2025 to satisfy tax withholding obligations in connection with the vesting of Restricted Stock Units (\"RSUs\") previously granted under the Genprex, Inc. (the \"Company\") 2018 Equity Incentive Plan."}],"balance_after":22471,"source":{"system":"sec-edgar","filing":"0001437749-25-004466","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595248/000143774925004466/rdgdoc.xml","form_type":"4"}},{"id":1340130,"issuer":{"id":8441,"kind":"organization","name":"Genprex, Inc."},"owners":[{"id":64221,"kind":"person","name":"Berger Mark Stanley","position":1,"cik":"0001700283","reported_name":"Berger Mark Stanley","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-12-06T22:48:11.000Z","date":"2024-12-05","kind":"grant","planned":false,"acquired":true,"shares":18250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This award of Restricted Stock Units (\"RSUs\") is granted under the Genprex, Inc. (the \"Company\") 2018 Equity Incentive Plan and vests 100% as of June 30, 2025, provided that the recipient continues to serve as a Service Provider (as defined in the Company's 2018 Equity Incentive Plan) through the applicable vesting date. Vested RSUs will be paid in shares of the Company's common stock, $0.001 par value, on a one-to-one basis."}],"balance_after":23056,"source":{"system":"sec-edgar","filing":"0001437749-24-036878","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595248/000143774924036878/rdgdoc.xml","form_type":"4"}},{"id":1628059,"issuer":{"id":8441,"kind":"organization","name":"Genprex, Inc."},"owners":[{"id":64221,"kind":"person","name":"Berger Mark Stanley","position":1,"cik":"0001700283","reported_name":"Berger Mark Stanley","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-02-21T21:34:33.000Z","date":"2024-02-18","kind":"tax_withholding","planned":false,"acquired":false,"shares":1319,"price":4.4,"value":5803.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld on February 18, 2024 to satisfy tax withholding obligations in connection with the vesting of Restricted Stock Units (\"RSUs\") previously granted under the Genprex, Inc. (the \"Company\") 2018 Equity Incentive Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This total represents the number of shares of Common Stock beneficially owned following this reported transaction and the 1-for-40 reverse stock split of the Company's Common Stock effected as of February 2, 2024."}],"balance_after":4806,"source":{"system":"sec-edgar","filing":"0001437749-24-005062","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595248/000143774924005062/rdgdoc.xml","form_type":"4"}},{"id":1998611,"issuer":{"id":8441,"kind":"organization","name":"Genprex, Inc."},"owners":[{"id":64221,"kind":"person","name":"Berger Mark Stanley","position":1,"cik":"0001700283","reported_name":"Berger Mark Stanley","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-02-22T23:35:05.000Z","date":"2023-02-18","kind":"grant","acquired":true,"shares":245000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This award of Restricted Stock Units (\"RSUs\") is granted under the Genprex, Inc. (the \"Company\") 2018 Equity Incentive Plan and vests in installments of 50% on the first anniversary of the date of grant and the remaining 50% on the second anniversary of the date of grant. Vested RSUs will be paid in shares of the Company's common stock, $0.001 par value, on a one-to-one basis."}],"balance_after":245000,"source":{"system":"sec-edgar","filing":"0001437749-23-004241","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595248/000143774923004241/rdgdoc.xml","form_type":"4"}},{"id":2407891,"issuer":{"id":8441,"kind":"organization","name":"Genprex, Inc."},"owners":[{"id":64221,"kind":"person","name":"Berger Mark Stanley","position":1,"cik":"0001700283","reported_name":"Berger Mark Stanley","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-02-08T21:32:18.000Z","date":"2022-02-04","kind":"grant","acquired":true,"shares":98750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option (the \"Option\") was granted under the Genprex, Inc. (the \"Company\") 2018 Equity Incentive Plan (the \"Plan\"). The Option shall vest and become exercisable as to one third (1/3) of the total number of shares (the \"Shares\") of the Company's common stock, $.001 par value subject to the Option on February 4, 2023 (the \"Vesting Commencement Date\") and thereafter shall vest and become exercisable as to an additional 1/24 of the remaining Shares subject to the Option on each monthly anniversary of the Vesting Commencement Date until fully vested and exercisable, in each case provided that the Optionee continues to serve as a Service Provider (as defined in the Plan) through the applicable vesting date."}],"balance_after":98750,"derivative":{"exercise_price":2.2,"exercise_date":"2023-02-04","expiration_date":"2032-02-04","underlying":"Common Stock","underlying_shares":98750},"source":{"system":"sec-edgar","filing":"0001437749-22-002744","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595248/000143774922002744/rdgdoc.xml","form_type":"4"}},{"id":2557331,"issuer":{"id":8441,"kind":"organization","name":"Genprex, Inc."},"owners":[{"id":64221,"kind":"person","name":"Berger Mark Stanley","position":1,"cik":"0001700283","reported_name":"Berger Mark Stanley","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-09-28T20:26:29.000Z","date":"2021-09-27","kind":"grant","acquired":true,"shares":550000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The options were granted outside of the Registrant's incentive award plans as an inducement grant pursuant to Nasdaq Listing Rule 5635(c)(4)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One-third of the options will vest on each of the first, second and third anniversaries of the date on which the Reporting Person commences employment with the Registrant."}],"balance_after":550000,"derivative":{"exercise_price":2.85,"exercise_date":"2022-09-27","expiration_date":"2031-09-27","underlying":"Common Stock","underlying_shares":550000},"source":{"system":"sec-edgar","filing":"0001437749-21-022776","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595248/000143774921022776/rdgdoc.xml","form_type":"4"}},{"id":2578644,"issuer":{"id":7435,"kind":"organization","name":"Actinium Pharmaceuticals, Inc.","symbol":"ATNM"},"owners":[{"id":64221,"kind":"person","name":"Berger Mark Stanley","position":1,"cik":"0001700283","reported_name":"Berger Mark Stanley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-09-03T21:04:11.000Z","date":"2021-09-01","kind":"grant","acquired":true,"shares":67164,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"This price represents the closing price of the Company's common stock on the date of the board of directors approval of the grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the terms of the Company's Amended and Restated 2013 Stock Plan and 2019 Stock Plan, 2% of the options will vest each month from September 1, 2021 until fully vested."}],"balance_after":67164,"derivative":{"exercise_price":6.07,"expiration_date":"2031-09-01","underlying":"Common Stock","underlying_shares":67164},"source":{"system":"sec-edgar","filing":"0001213900-21-046687","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1388320/000121390021046687/ownership.xml","form_type":"4"}},{"id":3057009,"issuer":{"id":7435,"kind":"organization","name":"Actinium Pharmaceuticals, Inc.","symbol":"ATNM"},"owners":[{"id":64221,"kind":"person","name":"Berger Mark Stanley","position":1,"cik":"0001700283","reported_name":"Berger Mark Stanley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-08-14T21:17:05.000Z","date":"2020-08-12","kind":"grant","acquired":true,"shares":46667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"This price represents the closing price of the Company's common stock on the date of the board of directors approval of the grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the terms of the Company's Amended and Restated 2013 Stock Plan and 2019 Stock Plan, 2% of the options will vest each month from August 12, 2020 until fully vested."}],"balance_after":46667,"derivative":{"exercise_price":9.55,"expiration_date":"2030-08-12","underlying":"Common Stock","underlying_shares":46667},"source":{"system":"sec-edgar","filing":"0001213900-20-022337","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1388320/000121390020022337/ownership.xml","form_type":"4"}},{"id":3460573,"issuer":{"id":7435,"kind":"organization","name":"Actinium Pharmaceuticals, Inc.","symbol":"ATNM"},"owners":[{"id":64221,"kind":"person","name":"Berger Mark Stanley","position":1,"cik":"0001700283","reported_name":"Berger Mark Stanley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Options to purchase common stock","published_at":"2019-07-16T21:07:01.000Z","date":"2019-07-12","kind":"grant","acquired":true,"shares":400000,"price":0.232,"value":92800.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Pursuant to the terms of the company's Amended and Restated 2013 Stock Plan, 2% of the options vest each month from the date of grant."}],"balance_after":400000,"derivative":{"exercise_price":0.232,"exercise_date":"2019-07-12","expiration_date":"2029-07-12","underlying":"Common Stock","underlying_shares":400000},"source":{"system":"sec-edgar","filing":"0001213900-19-012879","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1388320/000121390019012879/ownership.xml","form_type":"4"}},{"id":3605837,"issuer":{"id":7435,"kind":"organization","name":"Actinium Pharmaceuticals, Inc.","symbol":"ATNM"},"owners":[{"id":64221,"kind":"person","name":"Berger Mark Stanley","position":1,"cik":"0001700283","reported_name":"Berger Mark Stanley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-03-07T21:15:17.000Z","date":"2019-03-05","kind":"other","acquired":true,"shares":3500,"price":0.6,"value":2100.0,"ownership":{"direct":true},"balance_after":22500,"source":{"system":"sec-edgar","filing":"0001213900-19-003738","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1388320/000121390019003738/ownership.xml","form_type":"4"}},{"id":3865997,"issuer":{"id":7435,"kind":"organization","name":"Actinium Pharmaceuticals, Inc.","symbol":"ATNM"},"owners":[{"id":64221,"kind":"person","name":"Berger Mark Stanley","position":1,"cik":"0001700283","reported_name":"Berger Mark Stanley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Options to purchase common stock","published_at":"2018-07-17T21:15:05.000Z","date":"2018-07-13","kind":"grant","acquired":true,"shares":250000,"price":0.7829,"value":195725.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Pursuant to the terms of the company's Amended and Restated 2013 Stock Plan, 2% of the options vest each month from the date of grant."}],"balance_after":250000,"derivative":{"exercise_price":0.7829,"exercise_date":"2018-07-13","expiration_date":"2028-07-13","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001213900-18-009320","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1388320/000121390018009320/ownership.xml","form_type":"4"}},{"id":3988962,"issuer":{"id":7435,"kind":"organization","name":"Actinium Pharmaceuticals, Inc.","symbol":"ATNM"},"owners":[{"id":64221,"kind":"person","name":"Berger Mark Stanley","position":1,"cik":"0001700283","reported_name":"Berger Mark Stanley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Series B Warrants","published_at":"2018-03-19T21:04:36.000Z","date":"2018-03-06","kind":"other","acquired":true,"shares":10500,"price":0.5,"value":5250.0,"ownership":{"direct":true},"balance_after":10500,"derivative":{"exercise_price":0.7,"exercise_date":"2018-03-06","expiration_date":"2020-09-06","underlying":"Common Stock","underlying_shares":10500},"source":{"system":"sec-edgar","filing":"0001213900-18-003155","document":"f4030618berger_actinium.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1388320/000121390018003155/f4030618berger_actinium.xml","form_type":"4"}},{"id":3988961,"issuer":{"id":7435,"kind":"organization","name":"Actinium Pharmaceuticals, Inc.","symbol":"ATNM"},"owners":[{"id":64221,"kind":"person","name":"Berger Mark Stanley","position":1,"cik":"0001700283","reported_name":"Berger Mark Stanley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Series A Warrants","published_at":"2018-03-19T21:04:36.000Z","date":"2018-03-06","kind":"other","acquired":true,"shares":3500,"price":0.5,"value":1750.0,"ownership":{"direct":true},"balance_after":3500,"derivative":{"exercise_price":0.6,"exercise_date":"2018-03-06","expiration_date":"2019-03-06","underlying":"Common Stock","underlying_shares":3500},"source":{"system":"sec-edgar","filing":"0001213900-18-003155","document":"f4030618berger_actinium.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1388320/000121390018003155/f4030618berger_actinium.xml","form_type":"4"}},{"id":3988960,"issuer":{"id":7435,"kind":"organization","name":"Actinium Pharmaceuticals, Inc.","symbol":"ATNM"},"owners":[{"id":64221,"kind":"person","name":"Berger Mark Stanley","position":1,"cik":"0001700283","reported_name":"Berger Mark Stanley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-03-19T21:04:36.000Z","date":"2018-03-06","kind":"other","acquired":true,"shares":14000,"price":0.5,"value":7000.0,"ownership":{"direct":true},"balance_after":19000,"source":{"system":"sec-edgar","filing":"0001213900-18-003155","document":"f4030618berger_actinium.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1388320/000121390018003155/f4030618berger_actinium.xml","form_type":"4"}},{"id":4280396,"issuer":{"id":7435,"kind":"organization","name":"Actinium Pharmaceuticals, Inc.","symbol":"ATNM"},"owners":[{"id":64221,"kind":"person","name":"Berger Mark Stanley","position":1,"cik":"0001700283","reported_name":"Berger Mark Stanley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common stock","published_at":"2017-06-15T20:56:32.000Z","date":"2017-06-15","kind":"purchase","acquired":true,"shares":5000,"price":1.11,"value":5550.0,"ownership":{"direct":true},"balance_after":5000,"source":{"system":"sec-edgar","filing":"0001213900-17-006531","document":"f4061517berger_actinium.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1388320/000121390017006531/f4061517berger_actinium.xml","form_type":"4"}}]}